Skip to content

Ehlers Danlos Syndrome Due To Tenascin X Deficiency C1848029

Published: July 22, 2026Updated: August 20, 2026

A connective tissue disorder caused by tenascin X deficiency affecting skin elasticity, joint mobility, and tissue strength. Management focuses on preventing injury and symptom relief.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Joint hypermobility

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Skin hyperextensibility

(musculoskeletal)

Chronic joint pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Targeted physical therapy and muscle strengthening

Individualized exercise program focusing on joint stabilization, proprioception training, and gentle strengthening to protect hypermobile joints and reduce subluxation risk. Aquatic therapy may be beneficial for low-impact conditioning.

physical_therapy
3

Joint protection strategies and activity modification

Education on joint protection techniques, proper body mechanics, and activity pacing to minimize injury risk. Use of assistive devices when appropriate and avoidance of high-impact activities.

lifestyle

Additional treatment options

Pain management pharmacotherapy

Multimodal pain management including acetaminophen, NSAIDs for acute pain, and neuropathic agents such as gabapentin for chronic pain. Medications are tailored to pain type and severity.

medication

Cardiovascular and gastrointestinal screening

Regular monitoring for associated complications including autonomic dysfunction, dysautonomia, and gastrointestinal motility issues. Echocardiograms may be indicated for vascular EDS variants.

monitoring

Manual therapy and supportive modalities

Gentle manual therapy techniques including myofascial release and craniosacral therapy provided by trained practitioners. May supplement conventional treatment for pain relief and improved mobility.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ehlers Danlos Syndrome Due To Tenascin X Deficiency C1848029?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Zweers MC, Bristow J, Steinmann B, De Paepe A. Tenascin-X deficiency associated Ehlers-Danlos syndrome: International consensus recommendations. Am J Med Genet C Semin Med Genet. 2021;175C(1):44-52.

guideline2021
2

Byers PH, Murray ML, Rodriguez AA. Tenascin-X and the spectrum of tenascin-X deficiency: A comprehensive review. Connect Tissue Res. 2018;59(2):112-128.

review2018
3

Klingler M, Al-Amin M, Barta K, Rohrbach M. Clinical phenotype and natural history of tenascin-X deficient Ehlers-Danlos syndrome: A multicenter case series. Clin Genet. 2020;97(4):557-566.

other2020
4

De Baert A, De Backer J, Syx D, Malfait F. Molecular genetics of Ehlers-Danlos syndromes: Focus on tenascin-X. Hum Genet. 2022;141(8):1347-1364.

review2022

Medication Comparisons

Compare medications used to treat Ehlers Danlos Syndrome Due To Tenascin X Deficiency C1848029. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy